These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 3136331

  • 1. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, Greene DA.
    N Engl J Med; 1988 Sep 01; 319(9):548-55. PubMed ID: 3136331
    [Abstract] [Full Text] [Related]

  • 2. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF.
    N Engl J Med; 1988 Sep 01; 319(9):542-8. PubMed ID: 3136330
    [Abstract] [Full Text] [Related]

  • 3. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE, Larsen AB, Gregersen G.
    Ugeskr Laeger; 1987 Nov 09; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract] [Full Text] [Related]

  • 4. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity.
    Sima AA, Prashar A, Nathaniel V, Bril V, Werb MR, Greene DA.
    Diabet Med; 1993 Mar 09; 10(2):115-21. PubMed ID: 8458187
    [Abstract] [Full Text] [Related]

  • 5. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.
    Jaspan JB, Towle VL, Maselli R, Herold K.
    Metabolism; 1986 Apr 09; 35(4 Suppl 1):83-92. PubMed ID: 3083212
    [Abstract] [Full Text] [Related]

  • 6. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB, Herold K, Bartkus C.
    Am J Med; 1985 Nov 15; 79(5A):24-37. PubMed ID: 3000176
    [Abstract] [Full Text] [Related]

  • 7. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct 15; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 8. Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function.
    Martyn CN, Reid W, Young RJ, Ewing DJ, Clarke BF.
    Diabetes; 1987 Sep 15; 36(9):987-90. PubMed ID: 3111914
    [Abstract] [Full Text] [Related]

  • 9. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.
    Sima AA, Greene DA, Brown MB, Hohman TC, Hicks D, Graepel GJ, Bochenek WJ, Beg M, Gonen B.
    J Diabetes Complications; 1993 Sep 15; 7(3):157-69. PubMed ID: 8343610
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P.
    Drugs; 1986 Sep 15; 32 Suppl 2():43-55. PubMed ID: 3098544
    [Abstract] [Full Text] [Related]

  • 11. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ.
    FASEB J; 2002 Jan 15; 16(1):123-5. PubMed ID: 11709499
    [Abstract] [Full Text] [Related]

  • 12. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil.
    O'Hare JP, Morgan MH, Alden P, Chissel S, O'Brien IA, Corrall RJ.
    Diabet Med; 1988 Sep 15; 5(6):537-42. PubMed ID: 2974776
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological inhibition of aldose reductase in human diabetic neuropathy.
    Jaspan J.
    Drugs; 1986 Sep 15; 32 Suppl 2():23-9. PubMed ID: 2431859
    [Abstract] [Full Text] [Related]

  • 14. Prolonged aldose reductase inhibition in chronic peripheral diabetic neuropathy: effects on microangiopathy.
    Jennings PE, Nightingale S, Le Guen C, Lawson N, Williamson JR, Hoffman P, Barnett AH.
    Diabet Med; 1990 Jan 15; 7(1):63-8. PubMed ID: 2137066
    [Abstract] [Full Text] [Related]

  • 15. Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.
    Lewin IG, O'Brien IA, Morgan MH, Corrall RJ.
    Diabetologia; 1984 Jun 15; 26(6):445-8. PubMed ID: 6432615
    [Abstract] [Full Text] [Related]

  • 16. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
    Yue DK, Hanwell MA, Satchell PM, Turtle JR.
    Diabetes; 1982 Sep 15; 31(9):789-94. PubMed ID: 6819173
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA, Lattimer SA.
    Am J Med; 1985 Nov 15; 79(5A):13-7. PubMed ID: 3000175
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase inhibition for diabetic neuropathy.
    Lancet; 1983 Oct 22; 2(8356):969. PubMed ID: 6138528
    [No Abstract] [Full Text] [Related]

  • 20. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May 22; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.